Beckman Coulter, Inc., a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, and Olympus Corporation, a Tokyo-headquartered precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, announced today that they have entered into a definitive agreement…
The overall quality of laboratory operations has traditionally been evaluated using a combination of three variables: analytical quality, timeliness (turnaround time) and operational efficiency.
With the acquisition of Ventara Medical Systems, Roche hopes to move several steps further forward in their goal for personalised medicine that improves diagnostics and ultimately, clinical outcomes.
PCR plays a major part in medical diagnostics. From a few drops of blood, a tissue sample or a bacterial colony will be sufficient to confirm the presence of specific DNA. This approach relies, however, on a prior understanding of the mechanisms underlying the condition e.g. the causative organism in a viral disease. Standard primers are currently available for many pathogenic organisms which is…
Founded in 1991 in Shenzhen, China, the firm Mindray aims to deliver high-quality competitively priced medical devices to make healthcare accessible and affordable worldwide.
Olympus is presenting the AU480, the newest member of its clinical chemistry analyser family. With a throughput of up to 800 tests per hour, an ISE module and on board capacity of 63 different analytes, the Olympus AU480 is the ideal main analyser for small to medium-size laboratories.
Olympus will present the latest member of its clinical chemistry analyser family at Medica.
Hunt Biobank, Norway's biggest research biobank, is using Thermo Fisher Scientific Inc's Nautilus LIMS in its HUNT 3 study, to gather, store, manage, track and retrieve the biological data of approximately 100,000 people from Nord-Trøndelag County.
In the next 10-20 years, great changes will occur in the field of laboratory medicine.
An innovative robotic sample management system developed by the SME-led PMS project carries out complex sample transport operations rapidly and with a high level of reliability. It includes a new transport system based on magnetic hover railway technologies, a new laboratory information system and a special selective analyser. PMS partners are now predicting a substantial market share for their…
The future of the in vitro diagnostics (IVD) market looks promising. According to a new analysis from Frost & Sullivan, Western European IVD Market is estimated to reach $12.65 billion in 2014. The reason: Diseases depending on an aging population, such as infections, hike the demand for automated diagnostic tools.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
Laboratory automation of the 21st century demonstrates, every second, that in the 30 years since labs took their first tentative steps towards automation it has advanced by orders of magnitude - and moved far beyond the ambitions of its progenitors. Driven by the imperatives of greater efficiency, more precision and round-the-clock operation, ever more sophisticated forms of automation are now…
Work procedures have been radically simplified since, over one weekend five years ago, two specialist laboratories owned by Dr Helge Riegel GmbH Medical Supply Centre in Wiesbaden, Germany, installed two Olympus OLA2500 systems.
Lean Laboratory and Lean Automation are vital ingredients for the efficient and productive running of today's modern pathology laboratories. Automation serves as an essential endorsement to Lean, says Paul M Button, Senior Consultant at ValuMetrix, Ortho Clinical Diagnostics*
In today's clinical laboratory the technical staff performs quality inspections that are separate and distinct from normal laboratory testing quality control.
'Lean Laboratory' and 'Lean Automation' are vital ingredients for the efficient and productive running of today's modern Pathology laboratories. Automation serves as an essential endorsement to Lean, says Paul M Button, Senior Consultant at ValuMetrix, Ortho Clinical Diagnostics*
Olympus, which recently opened the global Research and Development Centre for Life Science in Munich, will invest around euro 15m in this project.
With 121 high level lectures and 65 published posters, Analytica 2008 - organised by the German Chemical Society (GDCh), the Society for Biochemistry and Molecular Biology (GBM) and the German United Society of Clinical Chemistry and Laboratory Medicine (DGKL) - was again a notable bio-chemistry event.
The Netherlands - Automating a laboratory is a very individual process with varying demands and needs. In most cases, the new systems have to be matched with existing instrumentation.
Barcelona, Spain - The Hospital Clinic is a tertiary level University Hospital that provides a broad range of services, from basic healthcare coverage to 550,000 people, to academic and advanced research activities. Hospital Clinic is a leading institution in certain pathologies, being the reference for Spain in different areas.
Automating a clinical laboratory is complicated and expensive.
Analytica, to be held in Munich for the 21st time, has become a leading international trade fair for instrumental analysis, laboratory technology and biotechnology, showcasing the entire range of equipment, solutions and services for laboratories in industry and research. About 400 exhibitors will fill five halls in the New Munich Trade Fair Centre.
Labs are Vital is a global initiative managed in the United Kingdom by a steering group that includes the Royal College of Pathologists, Association of Clinical Pathologists, Association for Clinical Biochemistry, Institute of Biomedical Science, British In Vitro Diagnostics Association and Abbott Diagnostics.
Rising costs, budgets and regulatory requirements have shaken up all medical areas except one — laboratory medicine. Now the wind has changed direction, affecting in-house labs, lab service providers and even manufacturers of related tools, as Daniela Zimmermann discovered during a meeting with Thomas Pracht, Managing Director of Olympus Life Science Europa GmbH.